查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1870009

抗凝血酶市場規模、佔有率和趨勢分析報告：按應用、原料、類型、地區和細分市場預測（2025-2033 年）

Antithrombin Market Size, Share & Trends Analysis Report By Application (Therapeutics, Diagnostics), By Source (Human, Recombinant Goat Milk), By Type, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

抗凝血酶市場摘要

2024年全球抗凝血酶市場規模估計為6.584億美元，預計2033年將達到9.972億美元。

預計從 2025 年到 2033 年，該市場將以 4.7% 的複合年成長率成長。凝血障礙（如深層靜脈栓塞症、肺動脈栓塞和遺傳性抗凝血酶缺乏症）的日益普遍是推動抗凝血酶市場成長的主要因素。

手術量增加、創傷病例增加以及妊娠併發症上升，都會增加血栓症的風險，這也導致了抗凝血酶治療需求的成長。抗凝血酶產業的發展動力源於血栓性栓塞症和凝血障礙病例的持續增加、人們對遺傳性抗凝血酶缺乏症認知的提高以及早期抗凝血治療重要性的認知。在美國，每年約有90萬人患有靜脈血栓栓塞症（VTE），其中住院期間及出院後不久的患者、接受癌症治療的患者以及孕婦的風險尤其高。據估計，每年有6萬至10萬美國人死於VTE，還有更多人遭受長期併發症。這種情況凸顯了有效預防和治療的緊迫性。

外科手術、創傷和妊娠併發症的增加進一步推動了抗凝血酶治療的需求。全球可用的治療方案包括血漿衍生產品和重組產品，其中重組產品因其安全性高、純度高和感染風險低而廣泛使用。在生物技術進步和監管核准的推動下，抗凝血酶在加護治療、心臟外科手術和產科領域的應用不斷擴展，持續推動全球抗凝血酶市場的發展。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 抗凝血酶市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 抗凝血酶市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 抗凝血酶市場：應用預測與趨勢分析

  • 使用細分儀表板
  • 抗凝血酶市場：按應用領域分析變化
  • 全球抗凝血酶市場規模及趨勢分析（按應用領域分類，2021-2033 年）
    • 治療
    • 診斷
    • 研究
    • 其他

第5章：抗凝血酶市場：依原料分類的估算與趨勢分析

  • 原料細分儀表板
  • 抗凝血酶市場：依原料分類的波動分析
  • 全球抗凝血酶市場規模及趨勢分析（2021-2033）
    • 人類
    • 改良山羊奶
    • 其他

第6章：抗凝血酶市場：按類型分類的估算與趨勢分析

  • 類型細分儀表板
  • 抗凝血酶市場：按類型分類的差異分析
  • 全球抗凝血酶市場規模及趨勢分析（按類型分類）（2021-2033 年）
    • 抗凝血劑
    • 抗血小板藥物
    • 溶栓藥物

第7章：抗凝血酶市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2024 年及 2030 年區域市佔率分析
  • 按地區分類的抗凝血酶市場：主要結論
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
  • 公司簡介
    • CSL
    • Grifols, SA
    • Takeda Pharmaceutical Company Limited.
    • Octapharma AG
    • LFB
    • ENDPOINT HEALTH, INC.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Medix Biochemica
Product Code: GVR-4-68040-781-8

Antithrombin Market Summary

The global antithrombin market size was estimated at USD 658.4 million in 2024 and is projected to reach USD 997.2 million by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The rising prevalence of coagulation disorders such as deep vein thrombosis, pulmonary embolism, and hereditary antithrombin deficiency primarily drives the antithrombin market.

Increasing surgical procedures, trauma cases, and complications during pregnancy that elevate thrombosis risk are also contributing to higher demand for antithrombin therapy. The antithrombin industry is driven by the steady rise of thromboembolic and coagulation disorders, growing awareness of hereditary antithrombin deficiency, and the importance of early anticoagulant therapy. In the U.S, 900,000 people are affected by venous thromboembolism (VTE) each year, with individuals at particularly high risk during or just after hospitalization, cancer treatment, or pregnancy. An estimated 60,000 to 100,000 Americans die annually from VTE, while many others experience long-term complications, thus highlighting the critical need for effective prevention and management.

Increasing surgical procedures, trauma incidents, and pregnancy-related complications have further amplified the demand for antithrombin therapy. Treatment options worldwide include plasma-derived and recombinant formulations, with recombinant products gaining wider acceptance due to higher safety, purity, and reduced infection risks. The expansion of their use in critical care, cardiac surgeries, and obstetric cases, supported by advancements in biotechnology and favorable regulatory approvals, continues to propel the global antithrombin market forward.

Global Antithrombin Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global antithrombin market report based on application, source, type, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Therapeutics
  • Diagnostics
  • Research
  • Other
  • Source Outlook (Revenue, USD Million, 2021 - 2033)
  • Human
  • Recombinant Goat Milk
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Anticoagulant
  • Antiplatelet
  • Thrombolytic Drugs
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Source
    • 1.2.3. Type
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Source
  • 1.9. List of Primary Source
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Source outlook
    • 2.2.3. Type outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Antithrombin Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Antithrombin Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Antithrombin Market: Application Estimates & Trend Analysis

  • 4.1. Application Segment Dashboard
  • 4.2. Antithrombin Market: Application Movement Analysis
  • 4.3. Global Antithrombin Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 4.3.1. Therapeutics
      • 4.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.3.2. Diagnostics
      • 4.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.3.3. Research
      • 4.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.3.4. Other
      • 4.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Antithrombin Market: Source Estimates & Trend Analysis

  • 5.1. Source Segment Dashboard
  • 5.2. Antithrombin Market: Source Movement Analysis
  • 5.3. Global Antithrombin Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
    • 5.3.1. Human
      • 5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.2. Recombinant Goat Milk
      • 5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.3. Others
      • 5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Antithrombin Market: Type Estimates & Trend Analysis

  • 6.1. Type Segment Dashboard
  • 6.2. Antithrombin Market: Type Movement Analysis
  • 6.3. Global Antithrombin Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
    • 6.3.1. Anticoagulant
      • 6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.2. Antiplatelet
      • 6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.3. Thrombolytic Drugs
      • 6.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Antithrombin Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Antithrombin Market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Sweden
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework/ reimbursement structure
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. China
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. India
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework/ reimbursement structure
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company heat map analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. CSL
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Grifols, S.A.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Takeda Pharmaceutical Company Limited.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Octapharma AG
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. LFB
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. ENDPOINT HEALTH, INC.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Siemens Healthineers AG
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Thermo Fisher Scientific Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Medix Biochemica
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global antithrombin market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 4 Global antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 5 Global antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 6 North America antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 8 North America antithrombin market, by sources, 2021 - 2033 (USD Million)
  • Table 9 North America antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 10 U.S. antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 11 U.S. antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 12 U.S. antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 13 Canada antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 15 Canada antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 16 Mexico antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 17 Mexico antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 18 Mexico antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 19 Europe antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 21 Europe antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 22 Europe antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 23 Germany antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 24 Germany antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 25 Germany antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 26 UK antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 27 UK antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 28 UK antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 29 France antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 30 France antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 31 France antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 32 Italy antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 33 Italy antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 34 Italy antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 35 Spain antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 36 Spain antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 37 Spain antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 38 Sweden antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 40 Sweden antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 41 Denmark antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 42 Denmark antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 43 Denmark antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 44 Norway antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 45 Norway antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 46 Norway antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 51 China antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 52 China antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 53 China antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 54 India antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 55 India antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 56 India antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 57 Japan antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 58 Japan antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 59 Japan antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 60 Australia antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 62 Australia antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 63 South Korea antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 64 South Korea antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 65 South Korea antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 66 Thailand antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 67 Thailand antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 68 Thailand antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 69 Latin America antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 71 Latin America antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 72 Latin America antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 73 Brazil antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 74 Brazil antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 75 Brazil antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 76 Argentina antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 77 Argentina antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 78 Argentina antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 83 South Africa antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 84 South Africa antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 85 South Africa antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 89 UAE antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 90 UAE antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 91 UAE antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 92 Kuwait antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 93 Kuwait antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 94 Kuwait antithrombin market, by type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Antithrombin market segmentation
  • Fig. 9 Market Snapshot
  • Fig. 10 Therapeutic approach and disease outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Antithrombin market dynamics
  • Fig. 13 Antithrombin market: Porter's five forces analysis
  • Fig. 14 Antithrombin market: PESTLE analysis
  • Fig. 15 Application market, 2021 - 2033 (USD Million)
  • Fig. 16 Therapeutics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Diagnostic market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Research market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Other market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Source market, 2021 - 2033 (USD Million)
  • Fig. 21 Human market estimates and forecast, 2021 - 2033
  • Fig. 22 Recombinant goat milk market estimates and forecast, 2021 - 2033
  • Fig. 23 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Type market, 2021 - 2033 (USD Million)
  • Fig. 25 Anticoagulant market, 2021 - 2033 (USD Million)
  • Fig. 26 Antiplatelet market, 2021 - 2033 (USD Million)
  • Fig. 27 Thrombolytic drugs market, 2021 - 2033 (USD Million)
  • Fig. 28 Antithrombin market revenue, by region
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. country dynamics
  • Fig. 32 U.S. antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 33 Canada country dynamics
  • Fig. 34 Canada antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 35 Mexico country dynamics
  • Fig. 36 Mexico antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 37 Europe antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 38 UK country dynamics
  • Fig. 39 UK antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 40 Germany country dynamics
  • Fig. 41 Germany antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 42 France country dynamics
  • Fig. 43 France antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 44 Italy country dynamics
  • Fig. 45 Italy antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 46 Spain country dynamics
  • Fig. 47 Spain antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 61 Australia country dynamics
  • Fig. 62 Australia antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 63 South Korea country dynamics
  • Fig. 64 South Korea antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 65 Thailand country dynamics
  • Fig. 66 Thailand antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil country dynamics
  • Fig. 69 Brazil antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 70 Argentina country dynamics
  • Fig. 71 Argentina antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 72 MEA antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 73 South Africa country dynamics
  • Fig. 74 South Africa antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 75 Saudi Arabia country dynamics
  • Fig. 76 Saudi Arabia antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 77 UAE country dynamics
  • Fig. 78 UAE antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 79 Kuwait country dynamics
  • Fig. 80 Kuwait antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 81 Company categorization
  • Fig. 82 Company market position analysis
  • Fig. 83 Strategic framework